Eko Murmur Analysis Software (EMAS) vs KardiaAI
AI Verdict
Choose Eko Murmur Analysis Software (EMAS) if…
Choose Eko Murmur Analysis Software (EMAS) if your primary need is AI-powered detection and differentiation of heart murmurs during a physical examination, particularly when integrating with Eko digital stethoscopes. This tool is ideal for clinicians seeking early clinical decision support for potential heart and lung disease in both adult and pediatric patients based on acoustic data.
View Eko Murmur Analysis Software (EMAS) →Choose KardiaAI if…
Choose KardiaAI if you require an FDA-cleared AI library for comprehensive analysis of ambulatory ECG rhythms to detect a wide range of cardiac conditions, including AFib, bradycardia, and tachycardia. This solution is best suited for integration into existing ECG devices or software platforms to provide medical-grade accuracy for ongoing heart rhythm data analysis.
View KardiaAI →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Eko Murmur Analysis Software (EMAS) | KardiaAI |
|---|---|---|
| Pricing | Starts at $119.99 per year for eko+ membership; enterprise solutions require contacting sales. | Subscription-based for advanced features and services. |
| Deployment | Cloud-based, Mobile App | Mobile app, cloud-based. |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
TieBoth tools offer a highly usable experience through dedicated mobile applications that integrate seamlessly with their respective hardware devices. Eko Murmur Analysis Software (EMAS) provides a mobile app for recording, playback, and saving heart sounds with Eko stethoscopes. KardiaAI, via the Kardia app and KardiaMobile devices, enables users to record, display, and receive instant analysis of ECGs on their smartphones, with a focus on ease of use and portability.
Clinical Value
TieBoth tools demonstrate significant clinical value and are FDA-cleared. EMAS is validated for detecting and differentiating heart murmurs, including distinguishing innocent from structural murmurs, with high sensitivity and specificity comparable to expert cardiologists. KardiaAI is cleared for detecting a broad range of cardiac rhythm abnormalities like AFib, bradycardia, and tachycardia, and its 12-lead ECG system offers performance comparable to hospital-grade ECGs for morphological abnormalities.
Pricing & Value
Eko Murmur Analysis Software (EMAS)Eko Murmur Analysis Software (EMAS) offers a free tier for basic AI murmur analysis within the Eko App, making initial access to its core functionality highly accessible. In contrast, KardiaAI's services are entirely subscription-based, requiring payment for all features. The availability of a free, clinically relevant tier for EMAS provides a stronger initial value proposition.
Enterprise Readiness
KardiaAIWhile both tools are HIPAA compliant, have BAAs, and FDA clearance, KardiaAI demonstrates superior enterprise readiness through its deployment as an API library and SDK. This architecture facilitates seamless integration into existing mobile apps, web platforms, and Electronic Health Record (EHR) systems, including being listed in Epic's App Orchard. EMAS, while offering PDF report generation for EHR compatibility, is more of a standalone device-app ecosystem.
Innovation
TieBoth companies are leaders in healthcare AI innovation. Eko's innovation lies in pioneering AI-powered auscultation, enabling the differentiation of innocent and structural heart murmurs, and integrating this into advanced digital stethoscopes that have received multiple design awards. AliveCor's innovation is evident in its comprehensive AI for a wide range of ECG rhythm and morphological detections, including the development of the world's first AI-powered handheld 12-lead ECG system, and its flexible API-first approach.
Support & Docs
KardiaAIBoth Eko and AliveCor offer robust customer support channels including help centers, FAQs, user manuals, email, and phone support. However, AliveCor (KardiaAI) provides explicit developer documentation for its API and SDK, facilitating deeper technical integration for enterprise clients and third-party developers. This comprehensive technical documentation for integration gives KardiaAI an edge in supporting a broader range of enterprise needs.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Eko Murmur Analysis Software (EMAS) | KardiaAI |
|---|---|---|
| Tool Name | Eko Murmur Analysis Software (EMAS) | KardiaAI |
| Company | Eko Devices | AliveCor |
| Description | FDA-cleared AI tool that integrates with Eko digital stethoscopes to detect and differentiate heart murmurs in adult and pediatric patients, providing clinical decision support for early detection of heart and lung disease. | FDA-cleared AI software library for analyzing ambulatory ECG rhythms, detecting various cardiac conditions like AFib, bradycardia, and tachycardia. |
| Primary Function | Murmur detection and differentiation | ECG rhythm analysis and cardiac condition detection |
| Key Detections | Differentiates innocent and structural heart murmurs | Atrial fibrillation, bradycardia, tachycardia, normal sinus rhythm, Sinus Rhythm with Premature Ventricular Contractions (PVCs), Sinus Rhythm with Wide QRS, Sinus Rhythm with Supraventricular Ectopy (SVE) |
| Integrates With | Eko digital stethoscopes (CORE 500, DUO, CORE) | Other ECG devices and software (via API library) |
Videos
Demos, reviews, and walkthroughs featuring Eko Murmur Analysis Software (EMAS) and KardiaAI.
Frequently Asked Questions
More Comparisons
More matchups featuring Eko Murmur Analysis Software (EMAS) or KardiaAI
Backers
Who funded each tool's parent company.